Egholm Michael reported tax withholding involving 97,627 shares of STANDARD BIOTOOLS INC. at $0.67 for −$65.6k on Aug 20, 2026

Tax withholding
Form 4 code F. Payment of an exercise price or tax liability by delivering or withholding securities in a Rule 16b-3 transaction.
President & CEO
President & CEO
Filed Aug 24, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$65,605.34Shares × reported price
Shares traded
97,627Common Stock
Price per share
$0.67Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
6,137,704Direct
Trade date
Aug 20, 2026Tax withholding
Filed
Aug 24, 2026, 5:04 PM ET4-day reporting delay
Accession
0001193125-26-363758Code F · Transaction 84093
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

LAB price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
LAB · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +35%1w ago +14%1d ago +3.1%
Returns since7d 0%30d +14%90d180d1y

Footnotes in full

F1: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units granted to the reporting person on May 20, 2024, March 21, 2025 and March 20, 2026, which grants were originally reported on Form 4s filed with the U.S. Securities and Exchange Commission on May 21, 2024, March 24, 2025 and April 8, 2026 respectively.